Prestige Biologics Co., Ltd. (KOSDAQ: 334970)
South Korea
· Delayed Price · Currency is KRW 5,570.00
-130.00 (-2.28%)
Nov 18, 2024, 1:01 PM KST
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 434.31 billion as of November 18, 2024. Its market cap has increased by 51.22% in one year.
Market Cap
434.31B
Enterprise Value
577.85B
Revenue
2.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,570.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 434.31B, a decrease of -29.18%. That is a compound annual growth rate of -8.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 15, 2024 | 441.28B | 63.77% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | 613.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition